Bullish Case: Call volume leads puts by 41% and bullish risk outweighs bearish 28% across tenors. IBD flags a buy zone with earnings early November and potential 4-year-high quarterly sales. The Helium PDF's densest mass sits at $230–240 near spot $228.53, near-ATM IV compresses to ~32.5% by January, and the $1B Aloha-class fleet build supports multi-year capacity/efficiency gains. Mean-reverting history plus contango argues for drift toward $235–245.

Bearish Case: Term structure is backwardated: Nov IV ~43.6% vs Jan ~35.8%, signaling near-term event risk into the early-November print. The 3.0x book valuation after a 146% one-year run leaves little cushion, deep-OTM put IV stays extremely rich (68–173%), and Helium's density puts a secondary shoulder at $200–210. Transpacific rate rollbacks, Guam crane disruption, or the n0n cyber-extortion wave could reprice quickly.

Potential Outcomes:

1. 36% — Rangebound $218–238 into the Nov print: flat six-day tape (+1.7% month), call-heavy flow; falsified if IV rises above ~45% while price holds $225.
2. 24% — Earnings pop to $240–260: IBD buy point 240.87, call skew firming; falsified if call IV lags puts post-print.
3. 22% — Pullback to $200–215: backwardation + steep put wing; falsified if MATX closes above $235 with cooling IV.
4. 12% — IV spike >50% and >15% drop: cyber/freight shock; deep-put IV already bids this tail.
5. 6% — Rally >$265: M&A/upgrade re-rating; falsified if upside-surface IV stays >55% without call flow.

October 24, 2026